Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical Orthopaedics and Related Research®
Published in: Clinical Orthopaedics and Related Research® 11/2010

01-11-2010 | Symposium: Highlights of the ISOLS/MSTS 2009 Meeting

Surgical Management of 121 Benign Proximal Fibula Tumors

Authors: Matthew P. Abdel, MD, Panayiotis J. Papagelopoulos, MD, Dsc, Mark E. Morrey, MD, Doris E. Wenger, MD, Peter S. Rose, MD, Franklin H. Sim, MD

Published in: Clinical Orthopaedics and Related Research® | Issue 11/2010

Login to get access

Abstract

Background

Tumors of the fibula comprise only 2.5% of primary bone lesions. Patients with aggressive benign tumors in the proximal fibula may require en bloc resection. Peroneal nerve function, knee stability, and recurrence are substantial concerns with these resections. The incidence and fate of these complications is not well-known owing to the small numbers of patients in previous reports.

Questions/purposes

We therefore analyzed the incidence of peroneal nerve palsy, knee stability, and local recurrence following surgical treatment of benign proximal fibula tumors.

Methods

We retrospectively reviewed the charts of 120 patients (121 tumors) with histologically confirmed aggressive benign tumors of the proximal fibula. There were 56 males and 64 females with an average age of 24 years (range, 2–64 years). The most common diagnosis was osteochondroma (38%) followed by giant cell tumor (19%). Pain (94%), palpable mass (39%), and peroneal nerve symptoms (12%) were the most common presenting symptoms. Of the 121 tumors, 56 (46%) underwent en bloc resection. The minimum followup was 2 years (mean, 9 years; range 2 to 49 years; median, 7.4 years).

Results

Postoperative complications included nine peroneal nerve palsies (six transient, three permanent), one deep venous thrombosis, and one wound dehiscence. No long-term knee instability was seen with repair of the lateral collateral ligament. Ten patients had recurrences, with 70% of local recurrences occurring in patients who underwent intralesional excision.

Conclusions

Given the higher recurrence rate with curettage, patients with aggressive proximal fibula tumors benefit from en bloc resection. The overall morbidity is low, but postoperative permanent peroneal palsy remains a concern (3%).

Level of Evidence

Level IV, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.
Literature
1.
Bickels J, Kollender Y, Pritsch T, Meller I, Malawer MM. Knee stability after resection of the proximal fibula. Clin Orthop Relat Res. 2007;454:198–201.CrossRefPubMed
2.
Bozkurt M, Yavuzer G, Tonuk E, Kentel B. Dynamic function of the fibula. Gait analysis evaluation of three different parts of the shank after fibulectomy: proximal, middle and distal. Arch Orthop Trauma Surg. 2005;125:713–720.CrossRefPubMed
3.
Bozkurt M, Yilmaz E, Atlihan D, Tekdemir I, Havitcioglu H, Gunal I. The proximal tibiofibular joint: an anatomic study. Clin Orthop Relat Res. 2003;406:136–140.CrossRefPubMed
4.
Danese CA, Singer A. Lateral approach to the popliteal artery trifurcation. Surgery. 1968;63:588–598.PubMed
5.
Dardik H, Dardik I, Veith FJ. Exposure of the tibial-peroneal arteries by a single lateral approach. Surgery. 1974;75:377–382.PubMed
6.
DeLee JC, Riley MB, Rockwood CA Jr. Acute straight lateral instability of the knee. Am J Sports Med. 1983;11:404–411.CrossRefPubMed
7.
Draganich LF, Nicholas RW, Shuster JK, Sathy MR, Chang AF, Simon MA. The effects of resection of the proximal part of the fibula on stability of the knee and on gait. J Bone Joint Surg Am. 1991;73:575–583.PubMed
8.
Erler K, Demiralp B, Ozdemir MT, Basbozkurt M. Treatment of proximal fibular tumors with en bloc resection. Knee. 2004;11:489–496.CrossRefPubMed
9.
Faezypour H, Davis AM, Griffin AM, Bell RS. Giant cell tumor of the proximal fibula: surgical management. J Surg Oncol. 1996;61:34–37.CrossRefPubMed
10.
Farooque M, Biyani A, Adhikari A. Giant cell tumours of the proximal fibula. J Bone Joint Surg Br. 1990;72:723–724.PubMed
11.
Gitelis S, Mallin BA, Piasecki P, Turner F. Intralesional excision compared with en bloc resection for giant-cell tumors of bone. J Bone Joint Surg Am. 1993;75:1648–1655.PubMed
12.
Grood ES, Noyes FR, Butler DL, Suntay WJ. Ligamentous and capsular restraints preventing straight medial and lateral laxity in intact human cadaver knees. J Bone Joint Surg Am. 1981;63:1257–1269.PubMed
13.
Kirgis A, Albrecht S. Palsy of the deep peroneal nerve after proximal tibial osteotomy. An anatomical study. J Bone Joint Surg Am. 1992;74:1180–1185.
14.
LaPrade RF, Wentorf F. Diagnosis and treatment of posterolateral knee injuries. Clin Orthop Relat Res. 2002;402:110–121.CrossRefPubMed
15.
Liu J, Hudkins PG, Swee RG, Unni KK. Bone sarcomas associated with Ollier’s disease. Cancer. 1987;59:1376–1385.CrossRefPubMed
16.
Malawer MM. Surgical management of aggressive and malignant tumors of the proximal fibula. Clin Orthop Relat Res. 1984;186:172–181.PubMed
17.
Marcove RC, Heelan RT, Huvos AG, Healey J, Lindeque BG. Osteoid osteoma. Diagnosis, localization, and treatment. Clin Orthop Relat Res. 1991;267:197–201.
18.
McDonald DJ, Sim FH, McLeod RA, Dahlin DC. Giant-cell tumor of bone. J Bone Joint Surg Am. 1986;68:235–242.PubMed
19.
Murray JA, Schlafly B. Giant-cell tumors in the distal end of the radius. Treatment by resection and fibular autograft interpositional arthrodesis. J Bone Joint Surg Am. 1986;68:687–694.PubMed
20.
Rock MG, Pritchard DJ, Unni KK. Metastases from histologically benign giant-cell tumor of bone. J Bone Joint Surg Am. 1984;66:269–274.PubMed
21.
Sung HW, Kuo DP, Shu WP, Chai YB, Liu CC, Li SM. Giant-cell tumor of bone: analysis of two hundred and eight cases in Chinese patients. J Bone Joint Surg Am. 1982;64:755–761.PubMed
22.
Unni KK. Dahlin’s Bone Tumors: General Aspects and Data on 11,087 Cases. Philadelphia, PA: Lippincott-Raven; 1996:1–9.
23.
Vail TP, Urbaniak JR. Donor-site morbidity with use of vascularized autogenous fibular grafts. J Bone Joint Surg Am. 1996;78:204–211.PubMed
24.
Youdas JW, Wood MB, Cahalan TD, Chao EY. A quantitative analysis of donor site morbidity after vascularized fibula transfer. J Orthop Res. 1988;6:621–629.CrossRefPubMed
Metadata
Title
Surgical Management of 121 Benign Proximal Fibula Tumors
Authors
Matthew P. Abdel, MD
Panayiotis J. Papagelopoulos, MD, Dsc
Mark E. Morrey, MD
Doris E. Wenger, MD
Peter S. Rose, MD
Franklin H. Sim, MD
Publication date
01-11-2010
Publisher
Springer-Verlag
Published in
Clinical Orthopaedics and Related Research® / Issue 11/2010
Print ISSN: 0009-921X
Electronic ISSN: 1528-1132
DOI
https://doi.org/10.1007/s11999-010-1464-8

Other articles of this Issue 11/2010

Clinical Orthopaedics and Related Research® 11/2010 Go to the issue

Symposium: Highlights of the ISOLS/MSTS 2009 Meeting

The Current Practice of Orthopaedic Oncology in North America

Symposium: Highlights of the ISOLS/MSTS 2009 Meeting

Computer-assisted Navigation in Bone Tumor Surgery: Seamless Workflow Model and Evolution of Technique

Symposium: Highlights of the ISOLS/MSTS 2009 Meeting

Cemented Endoprosthetic Reconstruction of the Proximal Tibia: How Long Do They Last?

Symposium: Highlights of the ISOLS/MSTS 2009 Meeting

Site-dependent Replacement or Internal Fixation for Postradiation Femur Fractures After Soft Tissue Sarcoma Resection

in Brief

In Brief: Statistics in Brief: Confidence Intervals: What is the Real Result in the Target Population?

Symposium: Highlights of the ISOLS/MSTS 2009 Meeting

Biographical Sketch: Otto Heinrich Warburg, PhD, MD